Your new post is loading...
At the annual meeting of the American Association of Cancer Researchers, presenters discuss strategies to improve the safety and effectiveness of reengineered T cells in eradicating tumors.
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection |
Scoop.it!
Via Krishan Maggon
CAR T Cell immunotherapy, TIL, ATC, TCR unpredictable toxicity at AACR 2015